Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Jason Mraz
AddedFeb 15, 2024
UpdatedMay 31, 2026
Jason Mraz

Jason Mraz

Co-Founder, Ospraie Ag Science

CrunchbaseLinkedInThe Org

Jason Mraz's Career

Ospraie Ag Science
Ospraie Ag Science
Co-Founder
Concarlo Holdings
Concarlo Holdings

New York, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Jason Mraz's Career

Ospraie Ag Science
Ospraie Ag Science
Investment Firm302018
Co-Founder

Leadership at Ospraie Ag Science

Dwight AndersonDwight AndersonCo-Founder

Similar to Ospraie Ag Science

Ospraie ManagementOspraie ManagementNew York City, NY, USest. 2004Ospraie ManagementNew York City, NY, US · est. 2004

NYC-based Ospraie Management invests in global commodities, basic industries, and eco-friendly agriculture.

175
ASW Venture PartnersASW Venture PartnersSan Francisco, CA, USest. 2018ASW Venture PartnersSan Francisco, CA, US · est. 2018

Investing and partnering in sustainable food & agriculture innovation.

5
AgroFidesAgroFidesNewburyport, MA, USest. 2019AgroFidesNewburyport, MA, US · est. 2019

AgroFides: Transforming cash-based farming into credit-based businesses.

$325k30
Ponderosa VenturesPonderosa VenturesLondon, Greater London, GBest. 2021Ponderosa VenturesLondon, Greater London, GB · est. 2021

Pre-seed and seed-stage investor, transforming food, agriculture, and ocean sectors for a sustainable future.

1
Concarlo Holdings
Concarlo Holdings
$7M192016New York, US
Co-Founder

Leadership at Concarlo Holdings

Michael HarringtonMichael HarringtonBoard Member
Jay CampbellJay CampbellBoard Member
Stacy BlainStacy BlainCo-Founder
Arthur KlausnerArthur KlausnerBoard Member
Mike MillerMike MillerBoard Member

Similar to Concarlo Holdings

Cello TherapeuticsCello TherapeuticsSan Diego, CA, USCancer Treatmentest. 2016Cello TherapeuticsSan Diego, CA, US · est. 2016

Nanoparticle developer specializing in cancer treatment solutions.

$8.7M8
Incyclix BioIncyclix BioDurham, NC, USCancer Treatmentsest. 2020Incyclix BioDurham, NC, US · est. 2020

Incyclix Bio, LLC: A next-gen cell cycle control firm, advancing precision cancer treatments.

$36M6
Palm TherapeuticsPalm TherapeuticsSan Diego, CA, USCancer Treatmentest. 2018Palm TherapeuticsSan Diego, CA, US · est. 2018

Revolutionizing cancer treatment with next-gen root-level therapeutics.

$991.1k7
OnCusp TherapeuticsOnCusp TherapeuticsNew York City, NY, USCancer Treatmentsest. 2021OnCusp TherapeuticsNew York City, NY, US · est. 2021

OnCusp Therapeutics: Innovating oncology treatments for global cancer patients.

$125M14

People Similar to Jason Mraz

Nugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakChi-hyung SongChi-hyung SongCo-Founder · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · DunamuBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailJoe YoungJoe YoungCo-Founder · Growers EdgeJavier TamashiroJavier TamashiroCo-Founder · OspreeJustin BruchJustin BruchBoard Member · AgFunderJohn SelepJohn SelepBoard Member · Sacramento AngelsTroy PearsallTroy PearsallCo-Founder · Osparna